JAZZ offering history
Every offering-related filing in Jazz Pharmaceuticals plc’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,001 filings back to Feb 28, 2017.
| Date | Filing | What it means | |
|---|---|---|---|
| Sep 6, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 5, 2021 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 11, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 1, 2017 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 23, 2017 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
JAZZ offering FAQ
When did JAZZ last execute an offering?
Per SEC filings, Jazz Pharmaceuticals plc's most recent priced offering document is a 8-K filed 2024-09-06. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did JAZZ last announce or register an offering?
No offering registration (S-1/S-3/F-1/F-3) appears in the filings reviewed back to 2017-02-28.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.